The Neurological Monitoring Devices Market in the Asia Pacific was worth USD 1.57 billion in 2022 and estimated to be growing at a CAGR of 8.2%, to reach USD 2.33 billion by 2027. Asia-Pacific has the fastest growing market because of large investments in healthcare research and the developing economy.
Electroencephalography is the technique of recording the spontaneous electrical activity of the brain over short periods of time. The device can map the electrical activity for neurology diagnostics, particularly for diseases such as epilepsy, brain disorders such as dementia, encephalopathy, sleep disorders, tumors, and stroke.
Continued investment in healthcare by the government and an increasing number of hospitals and neuro specialty clinics have continued driving the growth of these devices. Another factor contributing to growth is the high level of awareness in sleep diagnostics.
Lack of awareness among people about these devices is majorly obstructing the market growth.
This report has been segmented and sub-segmented the Asia Pacific Neurological Monitoring Devices Market into the following categories:
By Therapeutic Application:
Regionally, developing economies like India and China are making large investments in healthcare and medical research.
Leading companies operating in the APAC Neurological Monitoring Devices Market are CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org